Stephanie Meyer

Dr. Stephanie Meyer is a Researcher at Newcastle University, focusing on interdisciplinary research in toxicology, molecular biology, and environmental health. Her work spans investigations into chemical toxicity, cellular mechanisms in mitosis, and the effects of environmental and pharmaceutical agents on liver function. She collaborates extensively with academic and industry partners, contributing to advancements in in vitro hepatocyte models for drug safety testing and studies on endocrine disruptors.

Her research interests include hepatotoxicity, epigenetic regulation, and radiation biology. Recent studies highlight her exploration of ionic liquid toxicity, estrogen receptor interactions, and the development of novel biotechnological tools like the NanoBiT luciferase system. Dr. Meyer also addresses public health policy through analyses of patent law reforms affecting medicine accessibility in South Africa.

Key contributions include identifying xenobiotic triggers in autoimmune liver diseases and establishing B-13/H cell models for lipid dysregulation studies. Her work bridges basic science and applied toxicology, with implications for regulatory safety assessments and clinical practices.